Published-Ahead-of-Print December 4, 2008, DOI:10.2164/jandrol.108.006403
Journal of Andrology, Vol. 30, No. 3, May/June 2009
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.108.006403
Urinary Metabolites of Di(2-ethylhexyl) Phthalate Are Associated With Decreased Steroid Hormone Levels in Adult Men
JOHN D. MEEKER*,
ANTONIA M. CALAFAT
AND
RUSS HAUSER
,
From the * Department of Environmental Health
Sciences, University of Michigan, Ann Arbor, Michigan; the
Centers for Disease and Control and
Prevention, Atlanta, Georgia; the
Department
of Environmental Health, Harvard School of Public Health, Boston,
Massachusetts; and the
Vincent Memorial
Obstetrics and Gynecology Service, Andrology Laboratory and In Vitro
Fertilization Unit, Massachusetts General Hospital, Boston,
Massachusetts.
|
Correspondence to: Dr John Meeker, Department of Environmental Health
Sciences, University of Michigan School of Public Health, 6635 SPH Tower, 109
S Observatory St, Ann Arbor, MI 48109 (e-mail:
meekerj{at}umich.edu). |
Experimental animal studies have demonstrated that exposure to some
phthalates may be associated with altered endocrine function and adverse
effects on male reproductive development and function, but human studies are
limited. In the present study, urine and serum samples were collected from 425
men recruited through a US infertility clinic. Urinary concentrations of
mono(2-ethylhexyl) phthalate (MEHP), the hydrolytic metabolite of
di(2-ethylhexyl) phthalate (DEHP), and other phthalate monoester metabolites
were measured, along with serum levels of testosterone, estradiol, sex
hormone–binding globulin (SHBG), follicle-stimulating hormone,
luteinizing hormone, inhibin B, and prolactin. Two oxidized urinary
metabolites of DEHP were also measured in urine from 221 of the men. In
multiple regression models adjusted for potential confounders, MEHP was
inversely associated with testosterone, estradiol, and free androgen index
(FAI). An interquartile range increase in MEHP was associated with 3.7% (95%
confidence interval [CI], –6.8% to –0.5%) and 6.8% (95% CI,
–11.2% to –2.4%) declines in testosterone and estradiol,
respectively, relative to the population median hormone levels. There was
limited evidence for effect modification of the inverse association between
MEHP and FAI by the proportion of DEHP metabolites in the urine measured as
MEHP (MEHP%), which is considered a phenotypic marker of less efficient
metabolism of DEHP to its oxidized metabolites. Finally, the ratio of
testosterone to estradiol was positively associated with MEHP (P =
.07) and MEHP% (P = .007), suggesting potential relationships with
aromatase suppression. In conclusion, these results suggest that urinary
metabolites of DEHP are inversely associated with circulating steroid hormone
levels in adult men. However, additional research is needed to confirm these
findings.
Key words: Androgen, biomarker, endocrine, environment, human, estrogen, male reproduction, testosterone
This article has been cited by other articles:

|
 |

|
 |
 
P. Pocar, N. Fiandanese, C. Secchi, A. Berrini, B. Fischer, J. S. Schmidt, K. Schaedlich, and V. Borromeo
Exposure to Di(2-ethyl-hexyl) phthalate (DEHP) in Utero and during Lactation Causes Long-Term Pituitary-Gonadal Axis Disruption in Male and Female Mouse Offspring
Endocrinology,
February 1, 2012;
153(2):
937 - 948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. DeKeyser, E. M. Laurenzana, E. C. Peterson, T. Chen, and C. J. Omiecinski
Selective Phthalate Activation of Naturally Occurring Human Constitutive Androstane Receptor Splice Variants and the Pregnane X Receptor
Toxicol. Sci.,
April 1, 2011;
120(2):
381 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2009 by The American Society of Andrology.